Back to 
Woodline Partners LP
Woodline Partners LP
LGND2 quarters
Position history for Woodline Partners LP's holdings in Ligand Pharmaceuticals Incorporated
No. Woodline Partners exited its LGND (Ligand Pharmaceuticals) position in Q2 2020. Its Q1 2020 13F listed 20,544 shares worth $1.5M. Woodline Partners first reported LGND in Q1 2020 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$1.5M
Total Shares Change
-20,544
Quarter-by-Quarter History
Other major holders of LGND: BlackRock, Inc., Vanguard Group Inc.